Trial suggests GLP-1 combo therapy cuts fat while preserving muscle in obesity

A recent research study found that a combination of the GLP-1 receptor agonist semaglutide and bimagrumab, an antibody that ...
News-Medical.Net on MSN

Drug combination shows greater weight loss while preserving muscle mass

A recent research study found that a combination of the GLP-1 receptor agonist semaglutide and bimagrumab, an antibody that ...
Mirage News

GLP-1 Therapy Reduces Fat, Preserves Lean Mass

A recent research study found that a combination of the GLP-1 receptor agonist semaglutide and bimagrumab, an antibody ...